Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
09/23/2020 | Avenir Wellness Solutions, Inc. | CURR | Grant | Restricted Stock Unit | 61.7k | $0.00 | $0 | | 08/20/2020 |
08/20/2020 | Avenir Wellness Solutions, Inc. | CURR | Grant | Common Stock | 17.6k | $0.00 | $0 | | 08/20/2020 |
06/30/2020 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 29 | $0.00 | $0 | Held by Onbelay Capital Inc. | 06/26/2020 |
06/26/2020 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 39.6k | $0.61 | $24.1k | | 06/26/2020 |
03/31/2020 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 29 | $0.00 | $0 | Held by Onbelay Capital Inc. | 03/31/2020 |
12/31/2019 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 29 | $0.00 | $0 | Held by Onbelay Capital Inc. | 12/31/2019 |
09/30/2019 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 29 | $0.00 | $0 | Held by Onbelay Capital Inc. | 09/30/2019 |
09/13/2019 | Kintara Therapeutics, Inc. | DMPI | Purchase | Common Stock | 35k | $0.68 | $23.7k | Held by Registered Retirement Income Fund | 09/13/2019 |
09/13/2019 | Kintara Therapeutics, Inc. | DMPI | Purchase | Common Stock | 35k | $0.68 | $23.7k | | 09/13/2019 |
09/05/2019 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 39.6k | $0.61 | $24.1k | | 09/05/2019 |
09/05/2019 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 35.4k | $0.61 | $21.6k | | 09/05/2019 |
06/28/2019 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 29 | $0.00 | $0 | Held by Onbelay Capital Inc. | 06/28/2019 |
04/30/2019 | Kintara Therapeutics, Inc. | DMPI | Disposition | Performance Stock Units | 200k | $0.00 | $0 | | 04/30/2019 |
03/29/2019 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 282 | $0.49 | $138.2 | Held by Onbelay Capital Inc. | 03/29/2019 |
12/31/2018 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 282 | $0.34 | $96.4 | Held by Onbelay Capital Inc. | 12/31/2018 |
11/08/2018 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 40k | $0.61 | $24.4k | | 11/08/2018 |
09/28/2018 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 282 | $3.20 | $902.4 | Held by Onbelay Capital Inc. | 09/28/2018 |
06/29/2018 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 282 | $3.20 | $902.4 | Held by Onbelay Capital Inc. | 06/29/2018 |
03/30/2018 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 282 | $3.20 | $902.4 | by Onbelay Capital Inc. | 03/30/2018 |
11/16/2017 | Kintara Therapeutics, Inc. | DMPI | Purchase | Common Stock | 18.1k | $0.81 | $14.7k | See footnote | 11/15/2017 |
11/15/2017 | Kintara Therapeutics, Inc. | DMPI | Purchase | Common Stock | 1.9k | $0.81 | $1.5k | See footnote | 11/15/2017 |
09/29/2017 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 282 | $3.20 | $902.4 | Note | 09/29/2017 |
06/26/2017 | Kintara Therapeutics, Inc. | DMPI | Purchase | Common Stock | 4.2k | $3.60 | $15k | Note | 06/26/2017 |
10/03/2016 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 282 | $3.20 | $902.4 | Note | 10/03/2016 |